SARAH SAVAGE: Open Payments
NPI 1700225992 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $636 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| ABBVIE INC. | 2 | $51 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Lundbeck LLC | 1 | $30 |
| Amgen Inc. | 1 | $23 |
Products named: KESIMPTA, QULIPTA, CREXONT, INGREZZA, VYEPTI, UPLIZNA.
Industry payments across FL — which companies pay providers there.
